StockNews.AI
UNH
StockNews.AI
1 min

UNITEDHEALTH ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into UnitedHealth Group Incorporated on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

1. Bragar Eagel & Squire investigates claims against UNH due to alleged fiduciary breaches. 2. A class action lawsuit was filed against UNH on July 15, 2024. 3. Investors allege UNH misrepresented its anti-competitive safeguards during a class period. 4. UNH stock price fell by $27 after DOJ's renewed investigation news emerged. 5. The lawsuit could impact shareholder value significantly, with $25 billion lost.

6m saved
Insight
Article

FAQ

Why Bearish?

The announcement of investigations and stock price decline suggests investor uncertainty. Historical incidents show similar investigations typically lead to price drops.

How important is it?

The class action and ongoing investigations significantly impact UNH's reputation and financial stability.

Why Short Term?

The immediate effect of the lawsuit could pressure stock prices. This impact may persist until resolution or further developments occur.

Related Companies

AETCNCANTM
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In UnitedHealth (UNH) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in UnitedHealth between March 14, 2022, and February 27, 2024 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against UnitedHealth Group Incorporated (NYSE:UNH) on behalf of long-term stockholders following a class action complaint that was filed against UnitedHealth on July 15, 2024 with a Class Period from March 14, 2022, and February 27, 2024. Our investigation concerns whether the board of directors of UnitedHealth have breached their fiduciary duties to the company. Details: UnitedHealth is an American multinational health insurance and services company comprised of two distinct and complementary businesses: Optum and UnitedHealthcare. UnitedHealthcare provides health insurance to individuals, employers, and small businesses and is the largest insurance provider in the United States. Optum provides healthcare-related services, including software solutions, payment services, and data analytics.On January 6, 2021, UnitedHealth announced an agreement to acquire Change Healthcare (“Change”) and integrate it into its Optum business. Change is a healthcare technology company that provides data solutions aimed at improving clinical decision making and simplifying payment processes across the healthcare system. On February 24, 2022, the U.S. Department of Justice (“DOJ”) filed a lawsuit challenging UnitedHealth’s acquisition of Change. The DOJ alleged that the proposed acquisition would violate antitrust laws because the integration of Change and Optum would give UnitedHealth unparalleled access to information regarding nearly every health insurer, as well as health data on every single American. Ultimately, the court in the DOJ action permitted the acquisition, repeatedly crediting UnitedHealth’s firewall policy and commitment to preventing the sharing of data between UnitedHealthcare and Optum as the rationale for allowing the deal to proceed.The complaint alleges that, throughout the Class Period, UnitedHealth repeatedly assured investors that it had taken steps to avoid anti-competitive behavior, including by setting up “robust firewall processes” to prevent customer sensitive information (“CSI”) from being shared between UnitedHealthcare and Optum after the merger. Specifically, UnitedHealth explicitly stated that Optum “invests extraordinary time, money, and resources into safeguarding [CSI] and keeping it walled off from UnitedHealthcare” and that “UnitedHealth Group’s existing firewalls and data-security policies prohibit employees from improperly sharing external-customer CSI.” As a result of these misrepresentations, UnitedHealth stock traded at artificially inflated prices during the Class Period.The complaint further alleges that the truth emerged on February 27, 2024, when the Wall Street Journal reported that the DOJ had re-opened its antitrust investigation into UnitedHealth. In that article, the public learned for the first time that the DOJ was investigating the relationships between the Company’s various segments, including Optum. As a result of this disclosure, the price of UnitedHealth stock declined by $27 per share, erasing nearly $25 billion in shareholder value. Next Steps: If you are a long-term stockholder of UnitedHealth, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, P.C.Brandon Walker, Esq.Marion Passmore, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com

Related News